SHPH SHUTTLE PHARMACEUTICALS HOLDINGS INC Investor Conferences 8-K Filing 2025 - Investor Presentation On April 21, 2025, Shuttle Pharmaceuticals announced it will present at the Planet MicroCap Showcase on April 23, 2025, focusing on its Phase 2 trial of Ropidoxuridine for glioblastoma and advancements in its Shuttle Diagnostics subsidiary for prostate cancer diagnostics.Get access to all SEC 8-K filings of the SHUTTLE PHARMACEUTICALS HOLDINGS INC